The Valley Desk

NCT02547220 · Interventional trial

A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Overall registry status Terminated

Phase 3

Conditions Acute Antibody-Mediated Rejection (AMR)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov